One shot, two benefits: HIV treatment and contraception combined?

NCT ID NCT05044962

Recruiting now Disease control Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether giving young women (ages 15-24) in Kenya a long-acting injectable HIV medication along with a birth control implant is safe and works well. Researchers will check hormone levels and HIV viral suppression in 700 participants. The goal is to simplify care for women living with HIV who also want contraception.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cabotegravir/rilpivirine (injectable HIV medication) and etonogestrel implant (contraceptive)
What this could lead to: If successful, this could show that combining long-acting HIV treatment and birth control is safe and effective, making it easier for young women to manage both.
What could go wrong: This is an early-stage study focused on drug levels and feasibility, not a large-scale test of outcomes. Results may not apply to other populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONTRACEPTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONTRACEPTION DRUG-DRUG INTERACTION HIV INFECTIONS

Contacts and locations

Show contact details

Locations

Academic Model Providing Access to Healthcare (AMPATH) Moi Teaching And Referral Hospital (MTRH)
RECRUITING

Eldoret, Kenya, Kenya

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.